Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

Abroad (travel likely)RecruitingPHASE2

Conditions

Vulvo Vaginal Atrophy (VVA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nucleus Network, Saint Paul, Minnesota, United States
Contact: Study coordinator (Jennifer Bookey) · j.bookey@nucleusnetwork.com · (651) 641 2900
Contact: Principal Investigator (Amy Eastenson, MD)
Trisha Shamp, PhD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Vulvo Vaginal Atrophy · Genitourinary Syndrome of Menopause (GSM) · Vaginal Atrophy in Breast Cancer Patients

Abroad (travel likely)Recruiting

Brussels, Belgium

Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy

Vulvar Atrophy · Vaginal Atrophy

IsraelRecruiting

Hadera, Israel